LMAT''s capital management strategies continue to yield double-digit ROI from its invested capital. Read why we reiterate the buy call on LeMaitre Vascular.
→ Google Übersetzer
LeMaitre Vascular (NASDAQ:LMAT) has declared $0.125/share quarterly dividend, in line with previous.Payable Sept. 8; for shareholders of record Aug. 25; ex-div Aug.
→ Google Übersetzer
LeMaitre Vascular, Inc. (NASDAQ:NASDAQ:LMAT) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants J.J.
→ Google Übersetzer
The following slide deck was published by LeMaitre Vascular, Inc.
→ Google Übersetzer
LeMaitre Vascular press release (NASDAQ:LMAT): Q2 Non-GAAP EPS of $0.29 misses by $0.01.Revenue of $42.11M (+3.5% Y/Y) beats by $0.72M.
→ Google Übersetzer
Lemaitre Vascular Tops Q2 EPS by 4c
→ Google Übersetzer
LeMaitre Vascular (LMAT) is scheduled to announce Q2 earnings results on Thursday, July 28th, after market close.The consensus EPS Estimate is $0.30 (-25.0% Y/Y) and the consensus…
→ Google Übersetzer
LeMaitre has been beaten down lately however the pullback lends significant opportunity to add to a long-term compounder. Read more about LMAT stock here.
→ Google Übersetzer
Major players in the vascular graft market are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical. Major players in the vascular graft market are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical.
→ Google Übersetzer
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
→ Google Übersetzer
LeMaitre Vascular, Inc. (NASDAQ:NASDAQ:LMAT) Q1 2022 Earnings Conference Call April 28, 2022 17:00 ET Company Participants J.J.
→ Google Übersetzer
BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
→ Google Übersetzer
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
→ Google Übersetzer
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering will be offered by LeMaitre. In addition, LeMaitre intends to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering, on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
→ Google Übersetzer
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited results for the quarter ended June 30, 2021.
→ Google Übersetzer
Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?
→ Google Übersetzer
DUBLIN--(BUSINESS WIRE)--The "Vascular Patches Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com''s offering. Vascular patches are used for reconstruction of a damaged artery in the cardiovascular surgeries. It is usually placed at the site infection, which helps in reconstruction and maintenance of carotid arteries in postoperative wound infection. The vascular patches allows positive and safe angioplasty of an artery to be per
→ Google Übersetzer
Up Market Research (UMR) announces the release of a new report, Clot Management Devices Market Research Report 2021. The statistics and insights provide an in-depth look into the market and opportunities. The report provides a comprehensive analysis of key market shares, size, trends, and forecasts for the global Clot Management Devices market. It also covers []
→ Google Übersetzer
The global Vascular Patches market which projected a CAGR of approximately +7% in the midst of the estimate time span of 2020-2027. Coherent Market Insights has added a new report to its database that qualifies an expressive and professional look into
→ Google Übersetzer
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.
→ Google Übersetzer
Related Stocks: LMAT ,
→ Google Übersetzer
Stratagem Market Insights, is a leading global market research firm, is pleased to announce its new report on Artificial Blood Vessel market, forecast for 2021-2028. The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that
→ Google Übersetzer
Bioprosthetics Market Size, Status and Forecast 2021-2026 Global Bioprosthetics Market 2021-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Bioprosthetics market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Bioprosthetics restraining forces for this market, the []
→ Google Übersetzer
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021, at 1:30 PM EDT.
→ Google Übersetzer
LeMaitre Vascular (NASDAQ:LMAT) had its target price raised by Roth Capital from $53.00 to $55.00 in a report issued on Monday, Benzinga reports. The firm presently has a neutral rating on the medical instruments suppliers stock. Roth Capitals price target would suggest a potential upside of 15.21% from the companys current price. A number of []
→ Google Übersetzer
Related Stocks: LMAT ,
→ Google Übersetzer
Lemaitre Vascular Inc shares closed today at 1.6% below its 52 week high of $54.83, giving the company a market cap of $1B. The stock is currently up 31.2% year-to-date, up 82.7% over the past 12 months, and up 236.3% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 13.2% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 102.8% The company's stock price performance over the past 12 months beats the peer average by 150.8%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
→ Google Übersetzer
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Lawrence J. Jasinski sold 7,500 shares of the firm’s stock in a transaction on Monday, March 1st. The stock was sold at an average price of $51.28, for a total transaction of $384,600.00. Following the completion of the transaction, the director now directly owns 10,833 shares of the company’s stock, […]
→ Google Übersetzer
LeMaitre Vascular (NASDAQ:LMAT) declared a dividend payable on March 25, 2021 to its shareholders as of February 23, 2021. It was also announced that …
→ Google Übersetzer
LeMaitre Vascular announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
→ Google Übersetzer
LeMaitre Vascular (NASDAQ:LMAT) will be releasing its next round of earnings this Thursday, February 25. For all of the relevant information, here is your …
→ Google Übersetzer
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that… Read More »LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference
→ Google Übersetzer
Share this Stock Information BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November. David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020, at 8:00 AM ET. JJ Pellegrino, Chief Financial Officer, is scheduled to present at… Read More »LeMaitre Vascular to Present at Upcoming Investor Conferences
→ Google Übersetzer
LeMaitre Vascular announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
→ Google Übersetzer
Equities research analysts expect LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report $0.21 earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for LeMaitre Vascular’s earnings, with the highest EPS estimate coming in at $0.22 and the lowest estimate coming in at $0.18. LeMaitre Vascular reported earnings per share […]
→ Google Übersetzer
LeMaitre Vascular's (LMAT +12.8%) Q2 sales declined 16% Y/Y to $24.9M with sales in the Americas (-15%) and Europe/Middle East/Africa (-21%) due to COVID-1
→ Google Übersetzer
LeMaitre Vascular (NASDAQ:LMAT): Q2 GAAP EPS of $0.17 beats by $0.16. Revenue of $24.85M (-15.7% Y/Y) beats by $7.72M. Press Release
→ Google Übersetzer
BURLINGTON, Mass., July 10, 2020 -- LeMaitre Vascular, Inc. announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, after the… | July 10, 2020
→ Google Übersetzer
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
→ Google Übersetzer
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
→ Google Übersetzer
LeMaitre (LMAT) delivered earnings and revenue surprises of 19.05% and 3.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
→ Google Übersetzer
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
→ Google Übersetzer
LeMaitre Vascular, Inc. (LMAT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
→ Google Übersetzer
LeMaitre (LMAT) delivered earnings and revenue surprises of 9.52% and 1.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
→ Google Übersetzer
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
→ Google Übersetzer
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2019 Results Conference Call May 01, 2019 05:00 PM ET Company Participants J.J. Pellegrino - CFO George LeMaitre - Chai
→ Google Übersetzer
LMAT earnings call for the period ending March 31, 2019.
→ Google Übersetzer
LeMaitre (LMAT) delivered earnings and revenue surprises of -10.53% and 1.74%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
→ Google Übersetzer
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
→ Google Übersetzer